WeVote
Log In

Bill

Bill

S 693

An Act relative to non-medical switching

194th Legislature (2025-2026) Introduced by Brendan Crighton and 1 co-sponsor

Massachusetts bill restricts insurers from forcing patients to switch medications without medical reason, protecting treatment continuity for chronic conditions.

Bill reported favorably by committee and referred to the committee on Health Care Financing
0
WeVote Research Nonpartisan
Bill Summary · S 693

Legislative bill overview

S 693 addresses "non-medical switching," a practice where insurance companies or pharmacy benefit managers force patients to switch from their current medication to a different drug—typically a cheaper alternative—without medical justification. The bill aims to restrict this practice and protect patients' access to their prescribed medications.

Why is this important

Non-medical switching can disrupt treatment for chronic conditions, potentially causing health complications when patients are forced mid-course to medications that may be less effective for their individual circumstances. This practice particularly affects vulnerable populations with serious illnesses and creates friction between patients, doctors, and insurers over medication decisions.

Potential points of contention

  • Cost vs. access trade-off: Insurers argue switching reduces premiums; patient advocates counter that forced switches prioritize savings over health outcomes
  • Scope of restrictions: Defining what constitutes prohibited "non-medical switching" versus legitimate formulary management and prior authorization
  • Implementation burden: Determining how to enforce restrictions and handle exceptions without creating administrative gridlock for insurers and pharmacies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.